Literature DB >> 15949439

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.

Shairaz Baksh1, Stella Tommasi, Sarah Fenton, Victor C Yu, L Miguel Martins, Gerd P Pfeifer, Farida Latif, Julian Downward, Benjamin G Neel.   

Abstract

Tumor cells typically resist programmed cell death (apoptosis) induced by death receptors. Activated death receptors evoke Bax conformational change, cytochrome c release, and cell death. We report that the tumor suppressor gene RASSF1A is required for death receptor-induced Bax conformational change and apoptosis. TNFalpha or TRAIL stimulation induced recruitment of RASSF1A and MAP-1 to receptor complexes and promoted complex formation between RASSF1A and the BH3-like protein MAP-1. Normally, MAP-1 is inhibited by an intramolecular interaction. RASSF1A/MAP-1 binding relieved this inhibitory interaction, resulting in MAP-1 association with Bax. Deletion of the RASSF1A gene or short hairpin silencing of either RASSF1A or MAP-1 expression blocked MAP-1/Bax interaction, Bax conformational change and mitochondrial membrane insertion, cytochrome c release, and apoptosis in response to death receptors. Our findings identify RASSF1A and MAP-1 as important components between death receptors and the apoptotic machinery and reveal a potential link between tumor suppression and death receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15949439     DOI: 10.1016/j.molcel.2005.05.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  71 in total

1.  RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.

Authors:  M Lee Schmidt; Katharine R Hobbing; Howard Donninger; Geoffrey J Clark
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

2.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

3.  RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.

Authors:  Jane Levesley; Meryl E Lusher; Janet C Lindsey; Steven C Clifford; Richard Grundy; Beth Coyle
Journal:  Neuro Oncol       Date:  2011-08-31       Impact factor: 12.300

4.  Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.

Authors:  Xin Zhou; Ting-Ting Li; Xu Feng; Esther Hsiang; Yue Xiong; Kun-Liang Guan; Qun-Ying Lei
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

5.  The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.

Authors:  David Romano; Helene Maccario; Carolanne Doherty; Niall P Quinn; Walter Kolch; David Matallanas
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

6.  Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.

Authors:  David Romano; David Matallanas; Gregory Weitsman; Christian Preisinger; Tony Ng; Walter Kolch
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

7.  The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells.

Authors:  Angelique W Whitehurst; Rosalyn Ram; Latha Shivakumar; Boning Gao; John D Minna; Michael A White
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

8.  Integrating multiple microarray data for cancer pathway analysis using bootstrapping K-S test.

Authors:  Bing Han; Xue-Wen Chen; Xinkun Wang; Elias K Michaelis
Journal:  J Biomed Biotechnol       Date:  2009-05-26

9.  Paraneoplastic antigen-like 5 gene (PNMA5) is preferentially expressed in the association areas in a primate specific manner.

Authors:  Masafumi Takaji; Yusuke Komatsu; Akiya Watakabe; Tsutomu Hashikawa; Tetsuo Yamamori
Journal:  Cereb Cortex       Date:  2009-04-14       Impact factor: 5.357

10.  The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.

Authors:  Luke B Hesson; Thomas L Dunwell; Wendy N Cooper; Daniel Catchpoole; Anna T Brini; Raffaella Chiaramonte; Mike Griffiths; Andrew D Chalmers; Eamonn R Maher; Farida Latif
Journal:  Mol Cancer       Date:  2009-07-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.